enrofloxacin has been researched along with cefepime in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cattoir, V; Nordmann, P; Poirel, L | 1 |
| Albrecht, MT; Bergmann, JN; Homer, MJ; Phipps, AJ; Singh, VK | 1 |
2 other study(ies) available for enrofloxacin and cefepime
| Article | Year |
|---|---|
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Model for Evaluating Antimicrobial Therapy To Prevent Life-Threatening Bacterial Infections following Exposure to a Medically Significant Radiation Dose.
Topics: Acute Radiation Syndrome; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Cefepime; Enrofloxacin; Ertapenem; Gentamicins; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Linezolid; Radiation Dosage | 2022 |